Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors

Lignende værker

• Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
  af: Leich, E, et al.
  Udgivet: (2013)
• Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells
  af: Spector, Neil L., et al.
  Udgivet: (2007)
• Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
  af: Sewell, J M, et al.
  Udgivet: (2002)
• Effect of EGF-receptor tyrosine kinase inhibitor on Rab5 function during endocytosis
  af: Jozic, Ivan, et al.
  Udgivet: (2012)
• Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.
  af: Prywes, R, et al.
  Udgivet: (1986)